These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11589306)

  • 1. Human papilloma virus 16 E7 oncogene does not cooperate with RET/PTC 3 oncogene in the neoplastic transformation of thyroid cells in transgenic mice.
    Portella G; Borselli C; Santoro M; Gerbasio D; D'Armiento MR; Dumont JE; Ledent C; Rothstein JL; Vecchio G; Fusco A
    Oncol Res; 2001; 12(8):347-54. PubMed ID: 11589306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression in RET/PTC3 and E7 transgenic mouse thyroids: RET/PTC3 but not E7 tumors are partial and transient models of human papillary thyroid cancers.
    Burniat A; Jin L; Detours V; Driessens N; Goffard JC; Santoro M; Rothstein J; Dumont JE; Miot F; Corvilain B
    Endocrinology; 2008 Oct; 149(10):5107-17. PubMed ID: 18583418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human thyroid tumours, the puzzling lessons from E7 and RET/PTC3 transgenic mice.
    Jin L; Burniat A; Dumont JE; Miot F; Corvilain B; Franc B
    Br J Cancer; 2008 Dec; 99(11):1874-83. PubMed ID: 18985036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathological changes induced by selective inactivation of menin on the thyroid gland in RET÷PTC3 and E7 transgenic mice. A study of 77 cases.
    Căpraru OM; Berger N; Gadot N; Decaussin-Petrucci M; Zhang C; Borda A; Szilágyi T; Borson-Chazot F; Selmi-Ruby S
    Rom J Morphol Embryol; 2016; 57(1):91-8. PubMed ID: 27151693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early occurrence of metastatic differentiated thyroid carcinomas in transgenic mice expressing the A2a adenosine receptor gene and the human papillomavirus type 16 E7 oncogene.
    Coppée F; Gérard AC; Denef JF; Ledent C; Vassart G; Dumont JE; Parmentier M
    Oncogene; 1996 Oct; 13(7):1471-82. PubMed ID: 8875985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults.
    Elisei R; Romei C; Vorontsova T; Cosci B; Veremeychik V; Kuchinskaya E; Basolo F; Demidchik EP; Miccoli P; Pinchera A; Pacini F
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3211-6. PubMed ID: 11443191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid carcinomas in RET/PTC transgenic mice.
    Jhiang SM; Cho JY; Furminger TL; Sagartz JE; Tong Q; Capen CC; Mazzaferri EL
    Recent Results Cancer Res; 1998; 154():265-70. PubMed ID: 10027006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The RET/PTC3 oncogene: metastatic solid-type papillary carcinomas in murine thyroids.
    Powell DJ; Russell J; Nibu K; Li G; Rhee E; Liao M; Goldstein M; Keane WM; Santoro M; Fusco A; Rothstein JL
    Cancer Res; 1998 Dec; 58(23):5523-8. PubMed ID: 9850089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of connexin32 deletion on E7 or RET/PTC3 oncogene-driven growth and neoplastic transformation of the thyroid gland.
    Prost G; Bernier-Valentin F; Croset M; Rousset B
    Endocr Relat Cancer; 2009 Sep; 16(3):873-84. PubMed ID: 19509066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of siRNA on RET/PTC3 junction oncogene in papillary thyroid carcinoma: from molecular and cellular studies to preclinical investigations.
    Ali HM; Urbinati G; Chapuis H; Desmaele D; Bertrand JR; Couvreur P; Massaad-Massade L
    PLoS One; 2014; 9(4):e95964. PubMed ID: 24759995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered gene expression in immunogenic poorly differentiated thyroid carcinomas from RET/PTC3p53-/- mice.
    Powell DJ; Russell JP; Li G; Kuo BA; Fidanza V; Huebner K; Rothstein JL
    Oncogene; 2001 May; 20(25):3235-46. PubMed ID: 11423973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid carcinoma after Chernobyl latent period, morphology and aggressiveness.
    Williams ED; Abrosimov A; Bogdanova T; Demidchik EP; Ito M; LiVolsi V; Lushnikov E; Rosai J; Sidorov Y; Tronko MD; Tsyb AF; Vowler SL; Thomas GA
    Br J Cancer; 2004 Jun; 90(11):2219-24. PubMed ID: 15150580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Papillary thyroid carcinoma: 6 cases from 2 families with associated lymphocytic thyroiditis harbouring RET/PTC rearrangements.
    Mechler C; Bounacer A; Suarez H; Saint Frison M; Magois C; Aillet G; Gaulier A
    Br J Cancer; 2001 Dec; 85(12):1831-7. PubMed ID: 11747322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ret/PTC1 and ret/PTC3 in thyroid tumors from Chernobyl liquidators: comparison with sporadic tumors from Ukrainian and French patients.
    Di Cristofaro J; Vasko V; Savchenko V; Cherenko S; Larin A; Ringel MD; Saji M; Marcy M; Henry JF; Carayon P; De Micco C
    Endocr Relat Cancer; 2005 Mar; 12(1):173-83. PubMed ID: 15788648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of RET/PTC oncogene activation and clonality in thyroid nodules with incomplete morphological evidence of papillary carcinoma: a search for the early precursors of papillary cancer.
    Fusco A; Chiappetta G; Hui P; Garcia-Rostan G; Golden L; Kinder BK; Dillon DA; Giuliano A; Cirafici AM; Santoro M; Rosai J; Tallini G
    Am J Pathol; 2002 Jun; 160(6):2157-67. PubMed ID: 12057919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High iodine concentration attenuates RET/PTC3 oncogene activation in thyroid follicular cells.
    Fiore AP; Fuziwara CS; Kimura ET
    Thyroid; 2009 Nov; 19(11):1249-56. PubMed ID: 19725779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proinflammatory mediators and genetic background in oncogene mediated tumor progression.
    Russell JP; Engiles JB; Rothstein JL
    J Immunol; 2004 Apr; 172(7):4059-67. PubMed ID: 15034017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children.
    Nikiforov YE; Rowland JM; Bove KE; Monforte-Munoz H; Fagin JA
    Cancer Res; 1997 May; 57(9):1690-4. PubMed ID: 9135009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcript level modulates the inherent oncogenicity of RET/PTC oncoproteins.
    Richardson DS; Gujral TS; Peng S; Asa SL; Mulligan LM
    Cancer Res; 2009 Jun; 69(11):4861-9. PubMed ID: 19487296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinoma.
    Basolo F; Giannini R; Monaco C; Melillo RM; Carlomagno F; Pancrazi M; Salvatore G; Chiappetta G; Pacini F; Elisei R; Miccoli P; Pinchera A; Fusco A; Santoro M
    Am J Pathol; 2002 Jan; 160(1):247-54. PubMed ID: 11786418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.